» Articles » PMID: 38591824

Analysis of Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratios As Inflammatory Biomarkers in Chronic Kidney Disease: Impact of Parathyroidectomy

Overview
Journal J Bras Nefrol
Specialty Nephrology
Date 2024 Apr 9
PMID 38591824
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Secondary hyperparathyroidism (SHPT) is one of the causes for inflammation in CKD. We assessed the impact of parathyroidectomy (PTX) on neutrophil-to-lymphocyte (N/L) and platelet-to-lymphocyte (P/L) ratios in SHPT patients.

Methods: A total of 118 patients [hemodialysis (HD, n = 81), and transplant recipients (TX, n = 37)] undergoing PTX between 2015 and 2021 were analyzed.

Results: There was a significant reduction in calcium and PTH levels in both groups, in addition to an increase in vitamin D. In the HD group, PTX did not alter N/L and P/L ratios. In the TX group, there was a reduction in N/L and P/L ratios followed by a significant increase in total lymphocyte count.

Conclusion: N/L and P/L ratios are not reliable biomarkers of inflammation in SHPT patients undergoing PTX. Uremia, which induces a state of chronic inflammation in dialysis patients, and the use of immunosuppression in kidney transplant recipients are some of the confounding factors that prevent the use of this tool in clinical practice.

References
1.
Mendoza J, Isakova T, Ricardo A, Xie H, Navaneethan S, Anderson A . Fibroblast growth factor 23 and Inflammation in CKD. Clin J Am Soc Nephrol. 2012; 7(7):1155-62. PMC: 3386678. DOI: 10.2215/CJN.13281211. View

2.
Griveas I, Visvardis G, Papadopoulou D, Mitsopoulos E, Kyriklidou P, Manou E . Cellular immunity and levels of parathyroid hormone in uremic patients receiving hemodialysis. Ren Fail. 2005; 27(3):275-8. View

3.
Azevedo M, Bonan N, Dias G, Brehm F, Steiner T, Souza W . p-Cresyl sulfate affects the oxidative burst, phagocytosis process, and antigen presentation of monocyte-derived macrophages. Toxicol Lett. 2016; 263:1-5. DOI: 10.1016/j.toxlet.2016.10.006. View

4.
Bhuriya R, Li S, Chen S, McCullough P, Bakris G . Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2009; 53(4 Suppl 4):S3-10. DOI: 10.1053/j.ajkd.2008.11.029. View

5.
Azab B, Chainani V, Shah N, McGinn J . Neutrophil-lymphocyte ratio as a predictor of major adverse cardiac events among diabetic population: a 4-year follow-up study. Angiology. 2012; 64(6):456-65. DOI: 10.1177/0003319712455216. View